With this mounting evidence for the contribution of PIK3CA activating variants to parathyroid neoplasia, we set out to assess if such mutations are present in parathyroid adenomas and to thus evaluate their potential specificity for malignant parathyroid disease. Here, PIK3CA is linked to parathyroid gland adenoma.